Hand Sanitizer Spray Recalled for Above-Specification Chemical Contamination
Salon Technologies International is recalling Sanitizing Hand Spray 80% due to GMP deviations: the product contains acetaldehyde and acetal above specification limits. The recall affects 1,656 bottles distributed in Florida and Washington.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard involves chemical contamination (acetaldehyde and acetal above specification limits) in a skin-contact product, representing a risk of harm. Per the rubric, risk-of-harm products without reported injury score at 3 (High).
Plain-English summary
Salon Technologies International Inc is recalling Sanitizing Hand Spray 80%, packaged in 2 FL OZ (60 mL) bottles. The product is labeled with Lot #20-018 (expiration date 4/3/2023) and was distributed in Florida and Washington.
FDA analysis identified that the product contained acetaldehyde and acetal at levels above specification limits, constituting a GMP deviation. These volatile organic compounds should not be present in high concentrations in products applied to skin.
No illnesses or injuries have been reported. Consumers who have purchased this product should stop using it. Those with questions about the recall should contact the manufacturer or their local pharmacy.
The recalled product
- Product
- Sanitizing Hand Spray 80% (alcohol 80% v/v) Packaged in 2 FL OZ (60 mL) bottles, Salon Technologies International 8810 Commodity Circle STE 22-23, Orlando, FL 32819, UPC 6 96952 12904 5
- Manufacturer
- Salon Technologies International Inc
- Affected units
- 1,656
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 20-018 Exp. 4/3/2023
Distribution
Part of a larger recall action
This product is one of 2 recalled by Salon Technologies International Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Salon Technologies International Inc
See all →- SevereAntica Farmacista Hand Sanitizer Ocean Citron Recalled for Benzene Contamination
FDA (Drugs) · 2022-10-12
Same hazard · acetaldehyde
See all →- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-10-14
- HighHand Sanitizer Recalled for Excess Acetal and Acetaldehyde Contamination
FDA (Drugs) · 2023-11-29
- HighFoaming Hand Sanitizer Recalled for Elevated Acetaldehyde and Acetal Levels
FDA (Drugs) · 2023-05-31
- CriticalHand Sanitizer Recalled for Methanol and Acetaldehyde Contamination
FDA (Drugs) · 2023-03-15
- HighOhm Sanitizer Spray Recalled Due to Chemical Contamination
FDA (Drugs) · 2023-02-15
Similar recalls
- ModerateHand Sanitizer 80% Alcohol Recall Due to Acetaldehyde Contamination
FDA (Drugs) · 2021-09-15
- ModerateHand Sanitizer Recalled for Acetaldehyde and Acetal Above Limits
FDA (Drugs) · 2021-09-15
- HighHand Sanitizer Recalled for Manufacturing Defects and Chemical Impurities
FDA (Drugs) · 2022-09-21
- ModerateFDA Recalls Hand Sanitizer Gel Due to Manufacturing Deviations
FDA (Drugs) · 2020-09-02
- HighHand Sanitizer Recalled for Excess Chemical Impurities in Manufacturing
FDA (Drugs) · 2023-01-04
- ModerateHand Sanitizer Recalled for Subpotent Ethyl Alcohol Content
FDA (Drugs) · 2025-06-11